
Is Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) in Hot Water? Purcell & Lefkowitz LLP Launches Investigation into Possible Breaches of Fiduciary Duty by Board of Directors
NEW YORK, Dec. 19, 2024 /PRNewswire/ — Purcell & Lefkowitz LLP Investigates Potential Breach of Fiduciary Duty Claim A class action law firm, Purcell & Lefkowitz LLP, known for representing shareholders nationwide, is currently looking into a possible breach of fiduciary duty claim involving the board of directors of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX). If…